Advertisement

Topics

Companies Related to "A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotheraphy in Locally Advanced Adenocarcinoma of the Rectum" [Most Relevant Company Matches] - Page: 4 RSS

21:34 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotheraphy in Locally Advanced Adenocarcinoma of the Rectum" found in our extensive corporate database of over 50,000 company records.

Showing "Phase Study AZD6244 Combination With Capecitabine Radiotheraphy Locally" Companies 76–100 of 1,600+

Probably Relevant

PharmaTech Solutions Inc

PTS was founded in 1999 by a group of pharmaceutical research professionals who believed that a pioneering approach was required to solve the industry’s study enrollment problems. Through innovation and excellence, PTS has amassed the technology and experience to develop patient recruitment solutions that identify and address the core issues that can hinder enrollment. PTS understands that findi...


TABS Group, Inc.

The 2010 TABS Group Vitamin Study was conducted among 1,000 representative respondents aged 18-75 in the TNS panel. The responses were combined with TABS Group's proprietary modeling capabilities to derive the market size estimates for the Vitamin Category. The study was fielded in May 2010, and it replicated a study that was completed in January 2008. TABS Group is a leading provider of resear...

BioTime, Inc. and Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics, Inc. is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry leading platforms are based on its pluripotent stem cell and dendritic cell immunotherapy technologies. Asterias is focused on developing therapies to treat conditions in several medical areas where ther...


Intercell AG

Intercell AG is a fast growing biotechnology company with a clear strategy and focus on the design and development of novel vaccines for prevention and treatment of infectious diseases with substantial unaddressed medical need. The Company's unique position is based on the combination of antigens and immunizers (adjuvants) derived from its proprietary technology platforms and its in-house GMP manu...

GeNO LLC

GeNO LLC, founded in 2006, is a privately held, advanced development-stage technology company that is developing innovative nitric oxide (NO) generation and delivery platforms to enable the true potential of inhaled nitric oxide to be realized. The company is focused on applying the new technology to deliver inhaled nitric oxide to patients in a wide variety of settings, including ambulatory and ...

Chiltern

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries, has 24 offices and legal entities within 20 countries, resources in 37 countries and empl...

InnoPharm Limited

InnoPharm Ltd. is an independent Russian domestic contract research organization providing Phase II-IV clinical trials support. InnoPharm was established in 1991 and operates in Russia (mainly its European part), Ukraine and Belarus. We also perform data management and statistical processing of data generated in clinical studies conducted all over the world and organize regular and ad-hoc GCP semi...

Shield Therapeutics

Shield, founded in 2008, is an independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need. Shield is currently preparing to undertake a global pivotal Phase III study of its lead asset, ST10-021, for the treatment of iron deficiency anaemia associated with i...

PRC Clinical

PRC Clinical™ is a privately held Contract Research Organization (CRO) in the San Francisco Bay Area, offering Phase I-IV clinical trial management services for virtual, small and mid-size pharmaceutical, biotechnology and medical device companies. PRC Clinical has forged strategic alliances with key preferred providers to offer a full suite of CRO se...

Oncology Services India

Oncology Services (OS) is a leading internationally operating CRO with unmatched expertise and extensive experience in oncology drug development and study management. OS provides end to end solutions for drug development including services of Phase I to IV, regulatory affairs, consulting for drug development, medical writing, Data management and statistics, Quality assurance and pharmacovigilance.

Rigel Pharmaceuticals

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. We have achieved this goal since 2002. Our pioneering research focuses on intracellu...

iResearch

iResearch is a specialist Clinical Research Resourcing organisation providing a tailored management outsourcing service for the provision of interim medical, clinical and technical staff. The expertise of iResearch to provide Phase I services has been built on the delivery of a highly professional Phase I Bank Resource to three top ranking Pharmaceutical Companies over the last 3 years. We now of...

Peritech Pharma Ltd.

Founded in 2012, Peritech Pharma is a privately held specialty anal-rectal pharmaceutical company, targeting numerous indications with large markets and clear unmet medical needs. The Company's lead product, PP-110, a novel OTC anti-hemorrhoidal gel, is ready for commercialization in the US. Additional products include PP-120 for pruritus ani (anal itching...

CellAct Pharma

CellAct Pharma is focused on the development of innovative therapeutics for the treatment of cancers. CellAct‘s drug candidates target and modulate human molecules that have specific functions in tumor growth. A first small molecule compound, CAP7.1 is currently in a clinical Phase II study for the treatment of solid cancers. CellAct has received a €0.7...

Vitrolife AB (publ)

The fourth of the total of twelve patients included in the USA study for STEEN Solution™, and which enables sales approval in the important USA market, has now received a transplant. The first transplantation was carried out in September and four transplantations have thus now been carried out at four centres. A fifth centre, Duke University, has been ...

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. is a pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. The initial focus is on inhibitors of plasma kallikrein, which is an important component of the body’s inflammatory response and which, in excess, can l...

Quantum Clinical Research

Global Clinical Trial/Project Management Therapeutic Specialization Phase I Clinical Trial Mgmt Capabilities Phase II-III Capabilities Phase IIIb –IV Capabilities Post marketing Surveillance Treatment IND & Compassionate Use Regulatory Operations & QA Capabilities Worldwide Drug Safety Clinical Trial Monitoring CRA/Monitor Training Select Biometrics Capabilities

Scope International Life Sciences Hamburg AG

Scope International was founded in the end of 2000, with the first trial being conducted in January 2001. That makes it officially a young company, however, the founders and senior employees of the team contribute with more than 15 years working experience in the field of Phase I clinical research to the success of our organization. The board comprises Martin Geist, Claus Hemker and Christian Hilg...

Sg2

Sg2, a Vizient company, enables health care executives to make better, faster, more cost-effective strategic decisions through a unique combination of industry leading market analytics and unrivaled expertise. Visit Sg2.com for more information.

Midwest Institute For Clinical Research

Midwest Institute For Clinical Research® is a private research organization, established in the summer of 1988 to develop and implement clinical trials (Phase II-IV) in the Indianapolis metropolitan area. Our program is dedicated to provide the highest quality service to the pharmaceutical and medical device industry as well as to the volunteers who participate in these clinical trials. It is b...

Jennerex, Inc.

Jennerex, Inc. is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594 is currently in two mid-stage clinical trials in patients with primary liver cancer -- an international, randomized, Phase 2 dose-response clinical trial, and a Phase 2 study in combina...

Telormedix SA

Telormedix (www.telormedix.com), founded in October 2007, is a biopharmaceutical company focused on targeted immunity and modulation of the innate immune system for treating cancer and autoimmune diseases. The Company’s lead product, TMX-101, recently entered a Phase I/II clinical trial for the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). ...

Bioxyne

Bioxyne Limited (ASX:BXN) is an Australian immunotherapeutics business created in April 2012 through the reverse takeover of Probiomics (ASX: PCC) by privately held Hunter Immunology. The Company’s lead therapy, HI-164OV is based on the Company’s proprietary technology that uses the application of mucosal immunology to treat common human diseases.  HI-164OV, in Phase IIb clinica...

A+ Science AB

A+ Science is an established clinical research institute, characterised by a philosophy of strong academic partnership as the foundation for achieving commercial goals in clinical development. Our mission is to support product development by providing the concept, resources, expertise, and experience to design, rapidly recruit and report, high quality, and original phase I-IV clinical trials.Based...

International Pharmaceutical Research Center

International Pharmaceutical Research Center the commitment to unparalleled Quality Research. Our strength is our recognition from sponsors, investigators, and study subjects in conducting each study with dedication and a personal touch, while maintaining strict compliance with good clinical practice.


More From BioPortfolio on "A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotheraphy in Locally Advanced Adenocarcinoma of the Rectum"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks